Мозг. От хорошего к превосходному - Дэниэл Дж. Амен

Harrer, G., W. D. Hubner, and H. Podzuweit, «Effectiveness and Tolerance of the Hypericum Extract LI 16 °Compared to Maprotiline: A Multicenter Double-Blind Study», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S24–28.

Hubner, W. D, S. Lande, and H. Podzuweit, «Hypericum Treatment of Mild Depressions with Somatic Symptoms», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): SI2–14.

Johnson, D., et al. «Effects of Hypericum Extract LI 16 °Compared with Maprotiline on Resting EEG and Evoked Potentials in 24 Volunteers», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S44–46.

Kalb, R., R. D. Trautmann-Sponsel, and M. Kieser, «Efficacy and Tolerability of Hypericum Extract WS 5572 Versus Placebo in Mildly to Moderately Depressed Patients. A Randomized Double-Blind Multicenter Clinical Trial», Pharmacopsychiatry 34, no. 3 (2001): 96–103.

Laakmann, G., et al. «St. John’s Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy», Pharmacopsychiatry 31, Suppl 1 (1998): 54–59.

Philipp, М., R. Kohnen, and K. O. Hiller, «Hypericum Extract Versus Imipramine or Placebo in Patients with Moderate Depression: Randomised Multicentre Study of Treatment for Eight Weeks», British Medical Journal 319, no. 7224 (1998): 1534–38.

Sommer, H., and G. Harrer, «Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients», Journal of Geriatric Psychiatry and Neurology 7, Suppl 1 (1994): S9–11.

Witte, B., et al. «Treatment of Depressive Symptoms with a High Concentration Hypericum Preparation. A Multicenter Placebo-Controlled Double-Blind Study», Fortschrilt der Medizin 113, no. 28 (1995): 404–08.

Vorbach, E. U., W. D. Hubner, and К. H. Arnoldt, «Effectiveness and Tolerance of the Hypericum Extract LI 160 in Comparison with Imipramine: Randomized Double-Blind Study with 135 Outpatients», Journal of Geriatric Psychiatry and Neurology 7, Suppl. 1 (1994): S19–23.

5-ГТФ

Alino, J. J., L. Gutierrez, and М. I.. Iglesias, «5-Hydroxytryptophan (5-HTP) and a MAOI (Nialamide) in the Treatment of Depressions. A Double-Blind Controlled Study», International Pharmacopsychiatry 11, no. 1 (1976): 8–15.

Kahn, R. S., et al. «Effect of a Serotonin Precursor and Uptake Inhibitor in Anxiety Disorders: A Double-Blind Comparison of 5-Hydroxytryptophan, Clomipramine and Placebo», International Clinical Psychopharmacology 2, no. 1 (1987): 33–45.

Nardini, M., et al. «Treatment of Depression with L-5-Hydroxytryptophan Combined with Chlorimipramine, A Double-Blind Study», International Journal of Clinical Pharmacology Research 3, no. 4 (1983): 239–50.

Ribeiro, C. A., «L-5-hydroxytryptophan in the Prophylaxis of Chronic Tension-type Headache: A Double-Blind, Randomized, Placebo-Controlled Study. For the Portuguese Head Society», Headache 40, no. 6 (2000): 451–56.

Rousseau, J. J., «Effects of a Levo-5-Hydroxytryptophan-Dihydroergocristine Combination on Depression and Neuropsychic Performance: A Double-Blind Placebo-Controlled Clinical Trial in Elderly Patients», Clinical Therapeutics 9, no. 3(1987): 267–72.

Инозитол

Barak, Y., et al. «Inositol Treatment of Alzheimer’s Disease: A Double-Blind, Cross-over Placebo-Controlled Trial», Progress in Neuropsychopharmacological and Biological Psychiatry 20 (1996): 729–35.

Benjamin, J., et al. «Double-Blind, Placebo-Controlled, Crossover Trial of Inositol Treatment for Panic Disorder», American Journal of Psychiatry 152 (1995): 1084–86.

Einat, H., et al. «Inositol Reduces Depressive-like Behaviors in Two Different Models of Depression», Psychopharmacology 144 (1999): 158–62.

Fox, М., et al. «Inositol Treatment of Obsessive-Compulsive Disorder», American Journal of Psychiatry 153 (1996): 1219–21.

Levine, J., «Controlled Trials of Inositol in Psychiatry», European Neuropsychopharmacology 7 (1997): 147–55.

Levine, J., et al. «Double-Blind, Controlled-Trial of Inositol Treatment of Depression», American Journal of Psychiatry 152 (1995): 792–94.

Levine, J., et al. «CSF Inositol in Schizophrenia and High-Dose Inositol Treatment of Schizophrenic», European Neuropsychopharmacology 4 (1994): 487–90.

Seedat, S., and D.J. Stein, «Inositol Augmentation of Serotonin Reuptake Inhibitors in Treatment-Refractory Obsessive-Compulsive Disorder: An Open Trial», International Clinical Psychopharmacology 14 (1999): 353–56.

Валериана

Davidson, J. R. Т., and К. M. Connor, «Valerian», in Herbs for the Mind: Depression, Stress, Memory Loss, and Insomnia (New York: Guilford Press, 2000), 214–33.

Donath, F., et al., «Roots I: Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality», Pharmacopsychiatry 33 (2000): 47–53.

Dorn, M., «Valerian Versus Oxazepam: Efficacy and Tolerability in Nonorganic and Nonpsychiatric Insomniacs: A Randomized, Double-Blind, Clinical Comparative Study [in German]», Forschende Komplementarmedizin und Klassische Naturheilkunde 7 (2000): 79–84.

Russo, E. В., «Valerian», in Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies in Psychiatric Conditions (Binghamton, N.Y.: Haworth Press, (2001), 95–706.

Vorbach, E. U., R. Gortelmeyer, and J. Bruning, «Treatment of Insomnia: Effectiveness and Tolerance of a Valerian Extract», Psychopharmakotherapie 3 (1996): 109–15.

Глава 21

Amen, D. G., «Attention Deficit Disorder: A Guide for Primary Care Physicians», Primary Psychiatry 5, no. 7 (July 1998): 76–85.

«Change Your Brain, Change Your Life» (New York: Three Rivers Press, 1999).

«Images of Human Behavior», A Brain SPECT Atlas (Newport Beach, Calif.: Mindworks Press, 2001).

«Healing ADD: The Breakthrough Program That Allows You to See and Heal the Six Types of Attention Deficit Disorder» (New York: G.P. Putnam and Sons, 2001).

Amen, D. G., with L. Routh, «Healing Anxiety and Depression» (New York: Putnam, 2003).

Приложение

Amen, D. G., «Why Don’t Psychiatrists Look at the Brain: The Case for the Greater Use of SPECT Imaging in Neuropsychiatry», Neuropsychiatry Reviews 2, no. 1 (February 2001): 19–21.

Bonte, F. J., et al. «Brain Blood Flow in the Dementias: SPECT with Histopathologic Correlation in 54 Patients», Radiology 202 (1997): 793–97.

«Brain Perfusion Single Photon Emission Computed Tomography (SPECT) Using Tc-99m Radiopharmaceuticals 2.0. Approved 1999», in Society of Nuclear Medicine Procedure Guidelines Manual (June 2002).